Imugene Announces Extraordinary General Meeting for 2025
I'm PortAI, I can summarize articles.
Imugene Limited has announced an Extraordinary General Meeting on August 20, 2025, to be held in Sydney and online via Zoom. This meeting allows shareholders to engage in strategic decisions and vote on key issues, emphasizing the company's commitment to transparent governance. The latest analyst rating for Imugene (AU:IMU) is a Buy with a price target of A$0.42. The company focuses on developing cancer immunotherapies and has a current market cap of A$82.4M, with a year-to-date price performance of -70.19%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments